GSK893 is effective against both types of RNA virus infection May 11, 2016 Source: Bio Valley The drug, called GSK983, and chemist Chaitan Khosla from Stanford University found the drug to help human cells fight dengue virus and VEEV (Venezuela equine encephalitis) infection. Through large-scale screening, the authors found that the drug can effectively block the synthesis of viral RNA, thereby blocking the replication process of the virus. However, the lack of specificity is the only problem with the drug. The authors found that in addition to blocking viral RNA synthesis, GSK983 can also block the synthesis of DNA in human cells, so the drug kills humans while killing the virus. Researchers have reduced the risk of this side effect by performing a gradient dilution. By determining an effective concentration, the drug is able to kill the virus while ensuring that it does not affect endogenous DNA synthesis. This result indicates that GSK983 can be safely used in the treatment of animal and human diseases. This new discovery is part of the recent "Antiviral New Therapy Development" project at Stanford University. Researchers hope to find ways to suppress the common cold virus and Ebola virus, but they have planted beans and got the above results. Although it is still too early to say that researchers have achieved success, this discovery will be a very useful tool because most of the most toxic viruses in nature use RNA as a genetic material. DNA is our genetic material, and RNA is a tool that decodes and activates information stored in DNA. They are called temporary messengers. Although viruses hidden in the body may depend on DNA or RNA, RNA viruses usually have a high probability of mutation and are therefore highly resistant to vaccines. RNA itself is very unstable and has no corrective function, which means that RNA viruses are more likely to escape the recognition of the autoimmune system by the antigen type on the surface of the table. The Ebola virus and the Seca virus are among the famous representatives. Based on this research, researchers at Stanford University hope to develop a drug that can block viral infection by blocking RNA synthesis. The results are published in the journal Nature Chemical Biology.
Cosmetics are a mixture of various raw materials processed by reasonable allocation. There are many kinds of cosmetics with different properties. According to the cosmetic raw material performance and use, can be divided into two categories of substrate raw materials and auxiliary raw materials. The former is a kind of main raw material of cosmetics, which occupies a large proportion in cosmetics formula and plays a major role in cosmetics. The latter play a role in shaping, stabilizing, or imbuing cosmetics with color, fragrance and other properties that are extremely important in small amounts in cosmetic formulations. Cosmetics is with natural, synthetic or extract all sorts of action different material as raw material, via heating, agitation and emulsification wait for production program processing and become chemical mixture material.
tryptamine labs review,tryptamine supplement,tryptamine high Shaanxi YXchuang Biotechnology Co., Ltd , https://www.peptidenootropics.com